Mogayzel Peter J, Pierce Emily, Mills Joanne, McNeil Annette, Loehr Karen, Joplin Rebecca, McMahan Steve, Carson Kathryn A
Department of Pediatrics, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Pediatr Nurs. 2008 Nov-Dec;34(6):464-8; quiz 468-9.
Patients with cystic fibrosis (CF) frequently require prolonged aminoglycoside antibiotic therapy administered via central venous access devices (CVADs). Therefore, the effect of the volume of saline flush used prior to drawing blood on tobramycin levels obtained from CVADs was investigated to determine the potential for inappropriate drug dosing decisions.
This was a prospective study comparing tobramycin levels in blood samples obtained simultaneously from CVADs and from venipuncture. Two saline flushing protocols were tested. During Phase I, CVADs were flushed with 3 mL of normal saline. The saline flush volume was increased to 10 to 20 mL during Phase II. All patients had CF and ranged in age from 10 months to 20 years.
Twenty-eight paired peak levels were collected from 19 patients during Phase I of the study, and 30 paired samples were obtained from 20 patients using the revised collection protocol during Phase II. The median (range) peak tobramycin level obtained from CVADs using the original flushing protocol was 13.1 (3.4 to 52.0) compared to 9.5 (3.1 to 46.4) microg/mL for those drawn peripherally. Use of CVAD-obtained levels would have caused inappropriate dosing changes in 43% of cases. Increasing the saline flush volume improved the accuracy of the tobramycin levels obtained from CVADs. Median peak tobramycin levels using the modified flushing protocol were 17.3 (3.6 to 47.0) and 19.0 (3.3 to 42.1) microg/mL obtained from a CVAD or venipuncture, respectively. The intraclass correlation coefficient for this protocol was 0.90 (lower 95% confidence limit = 0.80). Additionally, 87% of these CVAD-obtained levels provided accurate information for clinical decision making.
Peak tobramycin levels drawn from CVADs flushed with a small flush volume are falsely elevated compared to those obtained by peripheral venipuncture. The use of a larger saline flush greatly improves the accuracy of these levels. Therefore, care should be taken to base clinical decisions on tobramycin levels obtained by peripheral venipuncture or following an appropriate large volume saline flush.
囊性纤维化(CF)患者经常需要通过中心静脉通路装置(CVAD)进行长时间的氨基糖苷类抗生素治疗。因此,研究了采血前生理盐水冲管量对从CVAD获得的妥布霉素水平的影响,以确定药物剂量决策不当的可能性。
这是一项前瞻性研究,比较了同时从CVAD和静脉穿刺采集的血样中的妥布霉素水平。测试了两种生理盐水冲管方案。在第一阶段,用3 mL生理盐水冲洗CVAD。在第二阶段,生理盐水冲管量增加到10至20 mL。所有患者均患有CF,年龄从10个月至20岁不等。
在研究的第一阶段,从19名患者中收集了28对峰值水平,在第二阶段,使用修订后的采集方案从20名患者中获得了30对样本。使用原始冲管方案从CVAD获得的妥布霉素峰值水平中位数(范围)为13.1(3.4至52.0),而外周采血获得的为9.5(3.1至46.4)μg/mL。使用CVAD获得的水平会导致43%的病例出现不当的剂量变化。增加生理盐水冲管量提高了从CVAD获得的妥布霉素水平的准确性。使用改良冲管方案时,从CVAD和静脉穿刺获得的妥布霉素峰值水平中位数分别为17.3(3.6至47.0)和19.0(3.3至42.1)μg/mL。该方案的组内相关系数为0.90(95%置信下限=0.80)。此外,这些从CVAD获得的水平中有87%为临床决策提供了准确信息。
与外周静脉穿刺获得的水平相比,用少量冲管液冲洗的CVAD所采集的妥布霉素峰值水平被错误地升高。使用较大体积的生理盐水冲管可大大提高这些水平的准确性。因此,临床决策应基于外周静脉穿刺获得的妥布霉素水平或在适当的大量生理盐水冲管后获得的水平。